33169424
2020 Nov 10.</span
We have read with great interest the article published in Hepatology by Jeffrey S. Morris et al(1). The authors carried out a retrospective study including 767 patients with hepatocellular carcinoma (HCC) and 200 healthy individuals as a control group to comprehensively construct a risk score from circulating biomarkers, and predict survival in HCC patients.

